Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Ulys, L.L.C. (CIK 1340098) reported $25.4M across 1 reported positions in its SEC 13F filing for 2021-03-31. Largest positions: LXRX ($25.4M, 100.00%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | LXRX | LEXICON PHARMACEUTICALS INC | $25.4M | 100.00% | 4.3M | Hold |
Source: SEC Form 13F filings · as of 2021-03-31